BIXT Insider Trading Activity and SEC Form 4 Filings
BIXT insider trading summary
Over the past 12 months, insiders at Bioxytran, Inc (BIXT) reported 1 open-market purchase worth $126K by 1 insider and no sales on SEC Form 4. Net insider buying was $126K.
Latest BIXT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 18, 2025 | Alan M Hoberman | Director | Buy | $126K (210,000 @ $0.60) |
| Aug 15, 2024 | David Platt | CEO | Buy | $198K (1,592,921 @ $0.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.